Physiological, Pathological and Pharmacological Interactions of Hydrogen Sulphide and Nitric Oxide in the Myocardium of Rats with Left Ventricular Hypertrophy
Author:
Open Access
- 16 January 2022
- journal article
- review article
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 44 (1) , 433-448
Abstract
Left ventricular hypertrophy (LVH) is characterized by increased myocardium thickness due to increased oxidative stress and downregulation of cystathione γ lyase (CSE) endothelial nitric oxide synthase (eNOS). Upregulation of CSE by hydrogen sulphide (H2S) and ENOS by L-arginine can arrest the progression of LVH individually. The present study explored the combined treatment of H2S and NO in the progression of LVH, and demonstrated that the response is due to H2S, NO or formation of either new molecule in physiological, pathological, and pharmacological in vivo settings of LVH. Exogenous administration H2S+NO in LVH significantly reduced (all p < 0.05) systolic blood pressure (SBP) and mean arterial pressure (MAP), LV index, heart index and oxidative stress when compared to the LVH group. There was downregulation of CSE mRNA and eNOS in the heart, and exogenous administration of H2S+NO groups upregulated eNOS MRNA while CSE MRNA remained downregulated in the hearts of the LVH group. Similar trends were observed with concentrations of H2S and NO in the plasma and tissue. It can be concluded that combined treatment of LVH with H2S and NO significantly ameliorate the progression of LVH by attenuating systemic hemodynamic and physical indices, and by decreasing oxidative stress. Molecular expression data in the myocardium of LVH depicts that combined treatment upregulated eNOS/NO while it downregulated CSE/H2S pathways in in vivo settings, and it is always eNOS/NO pathways which play a major role.Keywords
This publication has 47 references indexed in Scilit:
- Hydrogen sulfide attenuates cardiac hypertrophy and fibrosis induced by abdominal aortic coarctation in ratsMolecular Medicine Reports, 2012
- Oxidative stress and heart failureAmerican Journal of Physiology-Heart and Circulatory Physiology, 2011
- Hydrogen Sulfide Improves Survival After Cardiac Arrest and Cardiopulmonary Resuscitation via a Nitric Oxide Synthase 3–Dependent Mechanism in MiceCirculation, 2009
- Hydrogen sulfide and the vasculature: a novel vasculoprotective entity and regulator of nitric oxide bioavailability?Journal of Cellular and Molecular Medicine, 2009
- Sodium channel Scn1b null mice exhibit prolonged QT and RR intervalsJournal of Molecular and Cellular Cardiology, 2007
- Regulation of vascular nitric oxide in vitro and in vivo; a new role for endogenous hydrogen sulphide?British Journal of Pharmacology, 2006
- Impact of l-arginine on hydrogen sulfide/cystathionine-γ-lyase pathway in rats with high blood flow-induced pulmonary hypertensionBiochemical and Biophysical Research Communications, 2006
- Evidence for the formation of a novel nitrosothiol from the gaseous mediators nitric oxide and hydrogen sulphideBiochemical and Biophysical Research Communications, 2006
- The vasorelaxant effect of H2S as a novel endogenous gaseous KATP channel openerThe EMBO Journal, 2001
- The Possible Role of Hydrogen Sulfide as an Endogenous Smooth Muscle Relaxant in Synergy with Nitric OxideBiochemical and Biophysical Research Communications, 1997